Oxford Immune Algorithmics recently participated in the 41st GITEX Global event hosted at the Dubai World Trade Centre in Dubai, UAE.

Oxford Immune Algorithmics, growing by leaps and bounds, recently announced the appointment of Mr. Tony Cambridge to its Scientific Advisory Board.

Oxford Immune Algorithmics is proud to announce the appointment of internationally recognised innovator, Dr. Corey Cutler, to its Scientific Advisory Board.

An exceptional experience was planned for a select group of tech Startup founders last week in London. The Founder’s Forum & Mubadala Capital Ventures hosted a special Founder’s Forum event celebrating London’s Tech Week.

The mission of MBZUAI is to be the hub of fundamental AI research, training and transformation, and the global epicentre of research in the field. It is the world’s first university committed to AI, which makes the MBZUAI a perfect partner.

The UK’s Departament of International Trade recently announced the selection of Oxford Immune Algorithmics (OIA) as one of the health-tech companies that will participate in the UK’s Health Technology Showcase at Expo 2020.

Oxford Immune Algorithmics (OIA), creator of the Algocyte health-tech venture, has officially graduated from the Class No. 11 German-based SpinLab accelerator.

Oxford Immune Algorithmics’ trajectory as a Medtech and Biotech company continues to accelerate. The award-winning company recently announced the appointment of pioneering…

We are proud to announce that Oxford Immune Algorithmics (OIA), creator of Algocyte, is part of the Creative Destruction Lab-Toronto Health Diagnostics Stream’s 2020/21 graduating cohort…

Oxford Immune Algorithmics’ (OIA) continues to be acknowledged both internationally and in the U.K. The recent announcement of the award of…

Oxford Immune Algorithmics (OIA) has been announced the winner of Etihad’s AI international competition. Etihad Group Finance, owner of award-winning Abu Dhabi-based Etihad Airlines…

OIA’s flagship AI Medical Assistant, Algocyte, will be integrated into MyGlobalHome’s digital health ecosystem, allowing users to complete personal blood tests remotely at will…

Drawing on more than a decade of research in computational biology and systems medicine conducted at institutions such as the the University of Oxford…

Oxford Immune Algorithmics (OIA) is honoured to announce a new partnership with a major university in the UAE, Khawarizmi International College or KIC, made possible by Dr Assem Al-Hajj…

SpinLab, one of the best-ranked accelerating programmes in Europe based in Leipzig, Germany, has selected a handful of startups out of hundreds of applications, including OIA, to be supported and introduced…

Supported by HUB71, a new subsidiary of OIA, Immune Algorithmics Middle East Ltd, has officially started operations and opened an office in Abu Dhabi.

OIA has been accepted into the ‘CDL-recovery’ programme in Atlanta, U.S. with the purpose to explore the U.S. market and contribute to the world recovery during and after COVID-19.

Most global healthcare resources are focused on COVID19 and this is largely disrupting the continuum of care for patients with chronic diseases (Chudasama et al., 2020).

Algocyte is helping change how frequently and where people are monitored and get tested, but most people (89%) are still at high risk of infection from travelling…

IA’s CTO Dr. Jürgen Riedel and Senior AI Researcher Dr. Santiago Hernández-Orozco delivered an invited technical talk at the international conference AUTOMATA 2020, the 26th International Workshop on Cellular…